All times are listed in CEST (Central European Summer Time)

Browsing Over 470 Presentations

Sort By
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 32) Industry Satellite Symposium

Targeting KRASG12C: Kick-starting a KRAS revolution (ID 297)

Lecture Time
12:15 - 12:45
Speakers
  • Solange Peters (Lausanne, Switzerland)
Session Name
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 32)
Location
Auditorium 2, Bella Center, Copenhagen, Denmark
Date
Wed, 29.03.2023
Time
11:30 - 13:00
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 32) Industry Satellite Symposium

Q&A and summary (ID 298)

Lecture Time
12:45 - 13:00
Session Name
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 32)
Location
Auditorium 2, Bella Center, Copenhagen, Denmark
Date
Wed, 29.03.2023
Time
11:30 - 13:00
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 32) Industry Satellite Symposium

Chair’s introduction (ID 294)

Lecture Time
11:30 - 11:35
Speakers
  • Solange Peters (Lausanne, Switzerland)
Session Name
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 32)
Location
Auditorium 2, Bella Center, Copenhagen, Denmark
Date
Wed, 29.03.2023
Time
11:30 - 13:00
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 32) Industry Satellite Symposium

Treatment landscape for advanced NSCLC: Where are we now? (ID 295)

Lecture Time
11:35 - 11:55
Speakers
  • Jürgen Wolf (Cologne, Germany)
Session Name
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 32)
Location
Auditorium 2, Bella Center, Copenhagen, Denmark
Date
Wed, 29.03.2023
Time
11:30 - 13:00
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 32) Industry Satellite Symposium

How may we overcome resistance to CPI therapy? (ID 296)

Lecture Time
11:55 - 12:15
Speakers
  • Sanjay Popat (London, United Kingdom)
Session Name
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 32)
Location
Auditorium 2, Bella Center, Copenhagen, Denmark
Date
Wed, 29.03.2023
Time
11:30 - 13:00
Educational session

Insights in biology (ID 7)

Session Name
Mesothelioma (ID 5)
Speakers
  • Paul Baas (Amsterdam, Netherlands)
Date
Wed, 29.03.2023
Time
14:30 - 16:00
Room
Auditorium 4
Duration
20 Minutes
Multidisciplinary Tumour Board

Q&A (ID 82)

Session Name
Oligometastatic disease in oncogene addicted NSCLC (ID 19)
Date
Wed, 29.03.2023
Time
14:30 - 16:00
Room
Auditorium 1
Duration
20 Minutes
Educational session

Optimal first-line therapy for extensive-stage SCLC (ID 2)

Session Name
State of the art for small cell lung cancer: Unraveling recent data (ID 4)
Speakers
  • Charles M. Rudin (New York, United States of America)
Date
Wed, 29.03.2023
Time
14:30 - 16:00
Room
Auditorium 2
Duration
20 Minutes
Educational session

State of the art clinical treatment / Frontline studies (ID 8)

Session Name
Mesothelioma (ID 5)
Speakers
  • Anne S. Tsao (Houston, United States of America)
Date
Wed, 29.03.2023
Time
14:30 - 16:00
Room
Auditorium 4
Duration
20 Minutes
Educational session

Navigating salvage therapy for advanced SCLC (ID 3)

Session Name
State of the art for small cell lung cancer: Unraveling recent data (ID 4)
Speakers
  • Andrea Ardizzoni (Bologna, Italy)
Date
Wed, 29.03.2023
Time
14:30 - 16:00
Room
Auditorium 2
Duration
20 Minutes
Multidisciplinary Tumour Board

Case presentation (ID 78)

Session Name
Oligometastatic disease in oncogene addicted NSCLC (ID 19)
Speakers
  • Noemi Reguart Aransay (Barcelona, Spain)
Date
Wed, 29.03.2023
Time
14:30 - 16:00
Room
Auditorium 1
Duration
10 Minutes
Educational session

Novel targeted agents in mesothelioma (ID 9)

Session Name
Mesothelioma (ID 5)
Speakers
  • Dean A. Fennell (Leicester, United Kingdom)
Date
Wed, 29.03.2023
Time
14:30 - 16:00
Room
Auditorium 4
Duration
20 Minutes